Synthesis and antimycobacterial activity of novel 4-[5-(substituted phenyl)-1-phenyl-4,5-dihydro-1H-3-pyrazolyl]-2-methylphenol derivatives

被引:3
作者
Ali, Mohamed Ashraf [1 ]
Yar, Mohammad Shahar [1 ]
机构
[1] Jamia Hamdard, Fac Pharm, Dept Pharmaceut Chem, New Delhi 110062, India
关键词
D O I
10.1007/s00044-007-9000-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the present investigation, 4-hydroxy-3-methylacetophenone, on condensation with appropriate aldehydes in methanolic potassium hydroxide solution, yielded the corresponding chalcones (CI-XI). These corresponding chalcones were reacted with phenyl hydrazide in glacial acetic acid, which led to the formation of novel 4-[5-(substituted phenyl)-1-phenyl-4,5-dihydro-1H-3-pyrazolyll-2-methylphenol derivatives. All newly synthesized compounds were evaluated for their anti mycobacterial activities against isoniazid-resistant Mycobacterium tuberculosis using agar dilution. 4-[5-(4-Fluoro phenyl)-1-phenyl-4,5-dihydro-1H-3-pyrazolyl]-2-methylphenol showed good antimycobacterial activity, with a minimum inhibitory concentration of 0.62 mu g/ml.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 13 条
[1]   TUBERCULOSIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BARNES, PF ;
BLOCH, AB ;
DAVIDSON, PT ;
SNIDER, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (23) :1644-1650
[2]   PLASMA HYDRAZINE CONCENTRATIONS IN MAN AFTER ISONIAZID AND HYDRALAZINE ADMINISTRATION [J].
BLAIR, IA ;
TINOCO, RM ;
BRODIE, MJ ;
CLARE, RA ;
DOLLERY, CT ;
TIMBRELL, JA ;
BEEVER, IA .
HUMAN TOXICOLOGY, 1985, 4 (02) :195-202
[3]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[4]   A continuing survey of drug-resistant tuberculosis, New York City, April 1994 [J].
Fujiwara, PI ;
Cook, SV ;
Rutherford, CM ;
Crawford, JT ;
Glickman, SE ;
Kreiswirth, BN ;
Sachdev, PS ;
Osahan, SS ;
Ebrahimzadeh, A ;
Frieden, TR .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (05) :531-536
[5]   DOES PYRAZINOIC ACID AS AN ACTIVE MOIETY OF PYRAZINAMIDE HAVE SPECIFIC ACTIVITY AGAINST MYCOBACTERIUM-TUBERCULOSIS [J].
HEIFETS, LB ;
FLORY, MA ;
LINDHOLMLEVY, PJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1252-1254
[6]  
INDERLEID CB, 1991, ANTIBIOTICS LAB MED, P134
[7]   Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents [J].
Küçükgüzel, SG ;
Rollas, S .
FARMACO, 2002, 57 (07) :583-587
[8]  
Küçükgüzel SG, 2000, EUR J MED CHEM, V35, P761
[9]  
Nauduri D, 1998, CHEM PHARM BULL, V46, P1254, DOI 10.1248/cpb.46.1254
[10]   The need for new drugs against tuberculosis - Obstacles, opportunities, and next steps [J].
O'Brien, RJ ;
Nunn, PP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (05) :1055-1058